GlassScriptPhysician profile
Lynn W Blunt, JR.
NPI 1659372183
$5,175.11
in general payments reported to CMS, 2019-2025
46 companies · $880 in 2025
The $880 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,329 · 2020: $248 · 2021: $747 · 2022: $606 · 2023: $877 · 2024: $488 · 2025: $880.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,243.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $676.48 | 2019 | |
| Boston Scientific Corporation | $656.80 | 2019-2023 | Lithovue, Rezum Generator |
| Astellas Pharma US INC | $385.45 | 2019-2025 | Xtandi, Myrbetriq |
| Teleflex LLC | $351.60 | 2021-2025 | Urolift, Barrigel |
| Abbvie INC. | $299.41 | 2019-2025 | Lupron Depot |
| Urogen Pharma, INC. | $297.53 | 2020-2025 | Jelmyto |
| Procept Biorobotics Corporation | $209.84 | 2022-2025 | Aquabeam Robotic System |
| Antares Pharma, INC. | $167.17 | 2019-2022 | |
| Myovant Sciences INC. | $150.49 | 2021 | |
| Ferring Pharmaceuticals INC. | $141.52 | 2024-2025 | Adstiladrin |
| Myriad Genetic Laboratories, INC. | $140.83 | 2020-2023 | Prolaris |
| Janssen Biotech, INC. | $122.37 | 2019-2021 | |
| Blue Earth Diagnostics | $117.21 | 2019-2023 | |
| Pfizer INC. | $109.65 | 2019-2023 | |
| Coloplast Corp | $107.10 | 2021-2024 | Porges Coloplast, Vortek Hydro |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $105.64 | 2022-2025 | Tlando, Trelstar |
| Karl Storz Endoscopy-America | $104.42 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $101.98 | 2023-2025 | Pylarify |
| Calyxo, INC. | $84.96 | 2023-2025 | Cvac Aspiration System |
| Urovant Sciences INC | $66.66 | 2022 | |
| Photocure INC | $52.69 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $48.00 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $46.69 | 2024-2025 | Gemtesa |
| Healthtronics Stone Solutions, LLC | $46.01 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Baxter Healthcare | $44.23 | 2023 | Floseal |
| Laborie Medical Technologies Corp. | $42.96 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $40.83 | 2023 | Axonics, Bulkamid |
| Angiodynamics, INC. | $36.93 | 2021 | |
| Olympus America INC. | $35.49 | 2021-2025 | Itind System |
| Clarus Therapeutics INC. | $33.39 | 2021 | |
| Alnylam Pharmaceuticals INC. | $29.47 | 2023 | Givlaari |
| Ethicon US, LLC | $28.74 | 2024 | Harmonic, Echelon Flex |
| Abc Home Medical Supply, INC. | $26.15 | 2024 | |
| 180 Medical, INC. | $25.05 | 2020-2022 | |
| Abbott Laboratories | $23.19 | 2022 | |
| Ambu INC. | $23.07 | 2023 | |
| Immunitybio, INC. | $22.87 | 2025 | |
| Valencia Technologies Corporation | $22.04 | 2023 | Ecoin Device Kit |
| Merck Sharp & Dohme LLC | $21.65 | 2020 | |
| Therapeuticsmd, INC. | $21.53 | 2019 | |
| Halozyme INC | $21.24 | 2023 | |
| Sun Pharmaceutical Industries INC. | $20.19 | 2019 | |
| Tolmar, INC. | $18.41 | 2025 | Jatenzo, Eligard |
| Palette Life Sciences, INC. | $17.19 | 2022 | |
| Smith+Nephew, INC. | $15.45 | 2020 | |
| Endo Pharmaceuticals INC. | $14.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Blunt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.